(SMOT) VanEck Trust - VanEck - Ratings and Ratios

The VanEck Morningstar SMID Moat ETF is an exchange-traded fund that focuses on investing in small- and medium-capitalization companies with sustainable competitive advantages, as identified by Morningstars proprietary methodology. This methodology assesses both quantitative and qualitative factors to determine a companys moat, or its ability to maintain a competitive edge over time.

The fund is designed to track its benchmark index, which is comprised of companies that meet Morningstars criteria for having a sustainable competitive advantage. By investing at least 80% of its total assets in these securities, the fund provides investors with exposure to a diversified portfolio of mid-cap companies with strong potential for long-term growth.

Given the current technical data, including a last price of $32.75 and a 20-day simple moving average of $31.25, the ETF is showing a bullish trend. The 50-day simple moving average of $32.17 has been surpassed, indicating a potential upward momentum. However, the 200-day simple moving average of $34.04 is still above the current price, suggesting that the ETF is still below its long-term trend.

Using the provided technical and fundamental data, a forecast can be made. With an Average True Range (ATR) of 0.96, representing a 2.93% daily volatility, and considering the ETFs current price is near the lower end of its 52-week range ($28.40 - $37.06), there is potential for growth. If the ETF continues to trend upwards, breaking through its 50-day SMA and potentially challenging the 200-day SMA, it could be a buying opportunity. Conversely, if it falls back below the 20-day SMA, it may indicate a reversal.

Considering the Assets Under Management (AUM) of $343.53M USD, the ETF has a significant presence in the market, which can contribute to liquidity and potentially less volatility. Based on the current trends and assuming the Morningstar methodology continues to effectively identify companies with sustainable competitive advantages, a potential target price could be near the 52-week high of $37.06, representing a growth of approximately 13% from the current price.